Topic guide
Articles and reference material connected to this topic, organised for clear reading.
Reading path
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30 percent less likely to develop breast cancer than those who did not t…
Read guide →New research shows that while GLP-1 diabetes medications may slightly raise the risk of developing retinopathy, they also help protect against sight-threatening complications and reduce the likelihood of going…
Read guide →Metabolic and bariatric surgery delivers significantly greater weight loss and higher rates of obesity-related disease remission than glucagon-like peptide-1 receptor agonists (GLP-1s), according to one of the…
Read guide →A meta-analysis of 32 studies and 43,618 adults presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) shows that use of new classes of obesity drugs for weight loss is associate…
Read guide →Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. Review: The science of safety: adve…
Read guide →Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely prescribed for diabetes and obesity, but studies have found evidence that the medications may also influence behavior, such as supporting impuls…
Read guide →A large 'All of Us' analysis suggests people with current GLP-1 prescriptions drink less often, although the observational findings do not prove that the drugs reduce alcohol use. Study: Association of GLP-1 R…
Read guide →New research explores whether gut microbes may help explain why patients respond differently to GLP-1 weight-loss medications, revealing how diet, metabolism, and microbiome shifts could shape future personali…
Read guide →A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed, high-risk population, while leaving some cardiovascular endpoints unchanged.…
Read guide →A mouse study tracks how a leading GLP-1 drug alters gut bacteria over time, offering new clues to whether microbiome changes linger after dosing ends. Study: Effects of liraglutide on gut bacterial community …
Read guide →Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor (single agonists such as semaglutide) and also dual glucose-dependent insulinotropic …
Read guide →A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely used in blockbuster drugs like O…
Read guide →To tackle the inequity in medication access, a societal issue especially in developing nations, a team of undergraduate student-researchers at the University of Ottawa has developed a new biomanufacturing plat…
Read guide →Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers found encouraging metabolic signals but no statistically significant edge over plac…
Read guide →Can a diabetes medication improve memory, reduce addiction, and influence mood? Scientists uncover surprising effects of GLP-1 drugs on brain health—but are there hidden risks? Study: An analysis on the role o…
Read guide →Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease. Some rese…
Read guide →A once-daily oral small-molecule GLP-1 receptor agonist delivered progressive, dose-dependent weight loss without food or fluid restrictions, supporting larger phase 3 trials for long-term weight management. S…
Read guide →Semaglutide is a glucagon-like peptide-1 analog that can reduce hunger, thus supporting weight loss. In a recent New England Journal of Medicine study, researchers report that a weekly dose of semaglutide led …
Read guide →